Cristina Albarran, PharmD
- 2Articles
- 12.8KReads
- 2012–2014Active
- 9Collaborators
- 143Citations
About
Cristina Albarran, PharmD, has published research focused on the treatment of generalized anxiety disorder, particularly involving the use of agomelatine. Her work includes clinical studies comparing agomelatine to placebo and active comparators, as well as investigations into its role in preventing relapse. Albarran's publications appeared between 2012 and 2014 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
